Management of hyperbilirubinemia: quality of evidence and cost

Affiliations

Comment

Neil A Holtzman. Pediatrics. 2004 Oct.

. 2004 Oct;114(4):1086-8.

doi: 10.1542/peds.2004-1753.

¹ Department of Pediatrics and Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. nholtzma@jhsph.edu

No abstract available

Comment on

Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation.
American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Pediatrics. 2004 Jul;114(1):297-316. doi: 10.1542/peds.114.1.297. Pediatrics. 2004. PMID: 15231951
Cost-effectiveness of strategies that are intended to prevent kernicterus in newborn infants.
Suresh GK, Clark RE. Suresh GK, et al. Pediatrics. 2004 Oct;114(4):917-24. doi: 10.1542/peds.2004-0899. Pediatrics. 2004. PMID: 15466085